Alopecia Areata-Like Presentations With Mogamulizumab Therapy

    September 2023 in “ JAAD case reports
    Colin M. Kincaid, Ajay Sharma, Bonnie Lee, Lauren Pinter‐Brown, Janellen Smith, Kenneth G. Linden, Natasha Atanaskova Mesinkovska
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this case report, mogamulizumab treatment for Sézary syndrome was associated with rashes and alopecia in a patient, highlighting the potential for immune-mediated side effects and suggesting that such adverse effects might indicate a favorable prognosis, though further studies are needed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results